Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Wilson

Emergency Medicine Tampa, FL Medical Doctor

NPI 1811159452 CMS profile 671416

1 Davis Blvd, Tampa, FL 33606

Open in the dashboard

General payments

$538,456

502 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$373,855 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jason Wilson of Tampa, FL is reported in the CMS Open Payments database as having received $538,456 across 502 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $373,855 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,267 16
2024 General $71,249 40
2023 General $78,572 94
2022 General $133,729 138
2021 General $93,722 88
2020 General $48,356 43
2019 General $83,560 83

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Wilson
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Jason Wilson were reported at $29,267. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Jason Wilson Emergency Medicine median Middle half National median
2019 $83,560 $51 $18–$128 $163
2020 $48,356 $29 $16–$99 $114
2021 $93,722 $40 $18–$124 $132
2022 $133,729 $49 $20–$134 $149
2023 $78,572 $51 $22–$142 $160
2024 $71,249 $52 $22–$150 $164
2025 $29,267 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $175,474 174 payments
  2. AstraZeneca Pharmaceuticals LP $103,152 121 payments
  3. Gilead Sciences, Inc. $80,616 33 payments
  4. Portola Pharmaceuticals, Inc. $37,505 34 payments
  5. Alexion Pharmaceuticals, Inc. $34,678 39 payments
  6. Pfizer Inc. $22,671 24 payments
  7. Paratek Pharmaceuticals, Inc. $22,266 22 payments
  8. AcelRx Pharmaceuticals, Inc. $16,861 14 payments
  9. Abbott Laboratories $15,694 9 payments
  10. bioMerieux $11,177 4 payments
  11. Other $18,361 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $299,748 153 payments
  2. Consulting Fee $117,652 27 payments
  3. Travel and Lodging $61,605 133 payments
  4. Honoraria $42,909 20 payments
  5. Food and Beverage $12,886 165 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $3,500 1 payment
  7. Gift $147 2 payments
  8. Education $9 1 payment
Products named General payments · program years 2019–2025
  1. XARELTO $175,474 174 payments
  2. ANDEXXA Rare Disease $107,643 121 payments
  3. ANDEXXA Hematology/Neurology $37,505 34 payments
  4. Andexxa Hematology $30,178 38 payments
  5. ELIQUIS $22,671 24 payments
  6. NUZYRA $22,266 22 payments
  7. DSUVIA $16,861 14 payments
  8. I-STAT $15,525 6 payments
  9. Veklury $6,691 8 payments
  10. Epclusa $4,723 7 payments
  11. Other $4,173 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$17,644

Medicare's payments for the services billed

Medicare patients

129

Average age 71

Services billed

160

69 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Ischemic heart disease 59%
Diabetes 43%
Atrial fibrillation 40%
Chronic kidney disease 39%
Heart failure 36%
Depression 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $17,506
$17,506 — —
Veklury
  • Gilead Sciences, Inc. $6,691
$6,691 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

502 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record